{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T03:54:24Z","timestamp":1785902064334,"version":"3.56.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Janssen and Takeda"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.euroneuro.2020.04.001","type":"journal-article","created":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T09:54:24Z","timestamp":1589882064000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Iron homeostasis alterations and risk for akathisia in patients treated with antipsychotics: A systematic review and meta-analysis of cross-sectional studies"],"prefix":"10.1016","volume":"35","author":[{"given":"Georgios","family":"Schoretsanitis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriani","family":"Nikolakopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Guinart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph U.","family":"Correll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Kane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2020.04.001_bib0001","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1056\/NEJM199912233412607","article-title":"Disorders of iron metabolism","volume":"341","author":"Andrews","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"Suppl 1","key":"10.1016\/j.euroneuro.2020.04.001_bib0002","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0091-3057(82)90509-3","article-title":"Nutritional iron and dopamine binding sites in the rat brain","volume":"17","author":"Ashkenazi","year":"1982","journal-title":"Pharmacol., Biochem. Behav."},{"key":"10.1016\/j.euroneuro.2020.04.001_bib0003","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.euroneuro.2020.04.001_bib0004","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1192\/bjp.161.6.791","article-title":"Relationship between iron status and chronic akathisia in an inpatient population with chronic schizophrenia","volume":"161","author":"Barnes","year":"1992","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.04.001_bib0005","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1136\/jnnp.53.8.671","article-title":"Low plasma iron status and akathisia","volume":"53","author":"Barton","year":"1990","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.04.001_bib0006","first-page":"8051","article-title":"Salivary and serum biomarkers for the study of side effects of aripiprazole coprescribed with mirtazapine in rats","volume":"8","author":"Bogdan","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.euroneuro.2020.04.001_bib0007","series-title":"Introduction to Meta\u2010Analysis","article-title":"Meta-Regression","author":"Borenstein","year":"2009"},{"key":"10.1016\/j.euroneuro.2020.04.001_bib0008","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/S0140-6736(87)92687-0","article-title":"Low serum iron status and akathisia","volume":"1","author":"Brown","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.euroneuro.2020.04.001_bib0009","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1089\/cap.2012.0046","article-title":"Iron deficiency in pediatric patients in long-term risperidone treatment","volume":"23","author":"Calarge","year":"2013","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2020.04.001_bib0010","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jtemb.2018.10.009","article-title":"Comparison of serum essential trace metals between patients with schizophrenia and healthy controls","volume":"51","author":"Cao","year":"2019","journal-title":"J. Trace Element. Med. Biol."},{"key":"10.1016\/j.euroneuro.2020.04.001_bib0011","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/wps.20579","article-title":"Tardive dyskinesia risk with first- and second-generation antipsychotics in comparative randomized controlled trials: a meta-analysis","volume":"17","author":"Carbon","year":"2018","journal-title":"World Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.04.001_bib0012","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s12011-017-1039-6","article-title":"Association of serum trace elements with schizophrenia and effects of antipsychotic treatment","volume":"181","author":"Chen","year":"2018","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.euroneuro.2020.04.001_bib0013","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/01.jcp.0000117432.83724.6b","article-title":"Tardive dyskinesia and iron status","volume":"24","author":"Chong","year":"2004","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2020.04.001_bib0014","first-page":"82","article-title":"Iron deficiency and iron deficiency anemia in women. Scandinavian journal of clinical and laboratory investigation","volume":"244","author":"Coad","year":"2014","journal-title":"Supplementum"},{"key":"10.1016\/j.euroneuro.2020.04.001_bib0015","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/jnnp.2006.101014","article-title":"Improvement in neuroleptic-induced akathisia with intravenous iron treatment in a patient with iron deficiency","volume":"78","author":"Cotter","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.04.001_bib0016","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s40263-019-00625-3","article-title":"Medication-induced Akathisia with newly approved antipsychotics in patients with a severe mental illness: a systematic review and meta-analysis","volume":"33","author":"Demyttenaere","year":"2019","journal-title":"CNS Drugs"},{"key":"10.1016\/j.euroneuro.2020.04.001_bib0017","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control. Clin. Trials"},{"key":"10.1016\/j.euroneuro.2020.04.001_bib0018","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.mad.2013.11.005","article-title":"Iron status in the elderly","volume":"136\u2013137","author":"Fairweather-Tait","year":"2014","journal-title":"Mechan. Aging Develop."},{"key":"10.1016\/j.euroneuro.2020.04.001_bib0019","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/0006-3223(91)90128-9","article-title":"Serum iron and akathesia","volume":"30","author":"Friedman","year":"1991","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.04.001_bib0020","first-page":"476","article-title":"Is there a rationale for iron supplementation in the treatment of akathisia? A review of the evidence","volume":"56","author":"Gold","year":"1995","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.04.001_bib0021","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.euroneuro.2020.04.001_bib0022","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/1471-2458-13-154","article-title":"Are healthcare workers' intentions to vaccinate related to their knowledge, beliefs and attitudes? A systematic review","volume":"13","author":"Herzog","year":"2013","journal-title":"BMC public health"},{"key":"10.1016\/j.euroneuro.2020.04.001_bib0023","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.euroneuro.2020.04.001_bib0024","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0165-1781(00)00115-3","article-title":"Serum iron and ferritin in acute neuroleptic akathisia","volume":"93","author":"Hofmann","year":"2000","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2020.04.001_bib0025","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1600-0447.1991.tb03148.x","article-title":"Low serum iron in patients with neuroleptic-induced akathisia and dystonia under antipsychotic drug treatment","volume":"84","author":"Horiguchi","year":"1991","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.euroneuro.2020.04.001_bib0026","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.euroneuro.2020.04.001_bib0027","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1007\/s00213-017-4646-1","article-title":"Incidence and risk factors of acute akathisia in 493 individuals with first episode non-affective psychosis: a 6-week randomised study of antipsychotic treatment","volume":"234","author":"Juncal-Ruiz","year":"2017","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.euroneuro.2020.04.001_bib0028","doi-asserted-by":"crossref","DOI":"10.3390\/nu10111707","article-title":"Latent iron deficiency as a marker of negative symptoms in patients with first-episode schizophrenia spectrum disorder","volume":"10","author":"Kim","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.euroneuro.2020.04.001_bib0029","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0924-977X(02)00073-1","article-title":"Serum iron levels in schizophrenic patients with or without akathisia","volume":"13","author":"Kuloglu","year":"2003","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2020.04.001_bib0030","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12872-016-0260-0","article-title":"Glucagon-like peptide-1 receptor agonists and heart failure in type 2 diabetes: systematic review and meta-analysis of randomized and observational studies","volume":"16","author":"Li","year":"2016","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.euroneuro.2020.04.001_bib0031","doi-asserted-by":"crossref","DOI":"10.1177\/0706743718777392","article-title":"Movement disorders associated with antipsychotic medication in people with schizophrenia: an overview of cochrane reviews and meta-analysis","author":"Martino","year":"2018","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.04.001_bib0032","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1136\/bmj.1.6014.898-a","article-title":"Letter: Iron deficiency and restless legs","volume":"1","author":"Matthews","year":"1976","journal-title":"Br. Med. J."},{"key":"10.1016\/j.euroneuro.2020.04.001_bib0033","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0920-9964(99)00133-4","article-title":"Prevalence of extrapyramidal syndromes in psychiatric inpatients and the relationship of clozapine treatment to tardive dyskinesia","volume":"42","author":"Modestin","year":"2000","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2020.04.001_bib0034","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0006-3223(91)90229-F","article-title":"Serum iron levels and akathisia","volume":"29","author":"Nemes","year":"1991","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.04.001_bib0035","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1136\/jnnp.54.4.363","article-title":"Serum iron and transferrin in acute neuroleptic induced akathisia","volume":"54","author":"O'Loughlin","year":"1991","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.04.001_bib0036","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0006-3223(98)00137-1","article-title":"Serum iron in catatonic and noncatatonic psychotic patients","volume":"45","author":"Peralta","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.04.001_bib0037","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10578-015-0562-y","article-title":"Iron deficiency parameters in children and adolescents with attention-deficit\/hyperactivity disorder","volume":"47","author":"Percinel","year":"2016","journal-title":"Child Psychiatry Hum. Dev."},{"key":"10.1016\/j.euroneuro.2020.04.001_bib0038","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.sleep.2010.08.014","article-title":"Iron status and chronic kidney disease predict restless legs syndrome in an older hospital population","volume":"12","author":"Quinn","year":"2011","journal-title":"Sleep Med."},{"key":"10.1016\/j.euroneuro.2020.04.001_bib0039","first-page":"147","article-title":"Tardive akathisia, tardive dyskinesia, and serum iron status","volume":"14","author":"Sachdev","year":"1994","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2020.04.001_bib0040","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/BF02244089","article-title":"Acute drug-induced akathisia is not associated with low serum iron status","volume":"103","author":"Sachdev","year":"1991","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.euroneuro.2020.04.001_bib0041","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2174\/1570159X14666161208153644","article-title":"Revisiting antipsychotic-induced Akathisia: current issues and prospective challenges","volume":"15","author":"Salem","year":"2017","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.euroneuro.2020.04.001_bib0042","series-title":"Meta-Analysis with R","author":"Schwarzer","year":"2015"},{"key":"10.1016\/j.euroneuro.2020.04.001_bib0043","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/acps.12082","article-title":"Childhood catatonia, autism and psychosis past and present: is there an 'iron triangle'?","volume":"128","author":"Shorter","year":"2013","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.euroneuro.2020.04.001_bib0044","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.2147\/DDDT.S133205","article-title":"Treatment of tardive dyskinesia with VMAT-2 inhibitors: a systematic review and meta-analysis of randomized controlled trials","volume":"12","author":"Solmi","year":"2018","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.euroneuro.2020.04.001_bib0045","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/schbul\/sbx157","article-title":"Prevalence of catatonia and its moderators in clinical samples: results from a meta-analysis and meta-regression analysis","volume":"44","author":"Solmi","year":"2018","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2020.04.001_bib0046","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1192\/bjp.163.5.669","article-title":"Serum iron abnormalities in neuroleptic-induced akathisia in schizophrenic patients","volume":"163","author":"Soni","year":"1993","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.04.001_bib0047","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/0278-5846(94)90105-8","article-title":"Iron status in schizophrenic patients with acute neuroleptic-induced dystonic reactions","volume":"18","author":"Spina","year":"1994","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.04.001_bib0048","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1136\/jnnp.57.2.208","article-title":"Iron status, movement disorders, and acute phase response in elderly psychiatric patients","volume":"57","author":"Treloar","year":"1994","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.04.001_bib0049","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/0006-3223(92)90167-X","article-title":"Serum iron and akathisia","volume":"31","author":"Valles","year":"1992","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.04.001_bib0050","series-title":"Anemias. Concepts in the anemias of malignancies and renal and rheumatoid diseases","article-title":"Clinical aspects and laboratory \u2013 iron metabolism","author":"Wick","year":"2011"},{"key":"10.1016\/j.euroneuro.2020.04.001_bib0051","article-title":"Association between sarcopenia and hepatic encephalopathy: a systematic review and meta-analysis","author":"Wijarnpreecha","year":"2019","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.euroneuro.2020.04.001_bib0052","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1385\/BTER:98:2:109","article-title":"Plasma manganese, selenium, zinc, copper, and iron concentrations in patients with schizophrenia","volume":"98","author":"Yanik","year":"2004","journal-title":"Biol. Trace Elem. Res."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X20301073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X20301073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:55:42Z","timestamp":1760378142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X20301073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":52,"alternative-id":["S0924977X20301073"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2020.04.001","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Iron homeostasis alterations and risk for akathisia in patients treated with antipsychotics: A systematic review and meta-analysis of cross-sectional studies","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2020.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}